19.51
price down icon0.31%   -0.06
after-market アフターアワーズ: 18.56 -0.95 -4.87%
loading

Metsera Inc (MTSR) 最新ニュース

pulisher
Apr 17, 2025

Lilly stock up rallying Structure and Metsera (GPCR:NASDAQ) - Seeking Alpha

Apr 17, 2025
pulisher
Apr 14, 2025

Viking, Structure, Metsera on a tear as Pfizer drops obesity pill - MSN

Apr 14, 2025
pulisher
Apr 14, 2025

Viking stock on a tear after Pfizer setback (VKTX:NASDAQ) - Seeking Alpha

Apr 14, 2025
pulisher
Apr 07, 2025

Metsera plunges 44% after InvestingPro’s overvaluation warning By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Mar 27, 2025

Exclusive: Metsera CEO on what it takes to build an obesity biotech in 2025 - Endpoints News

Mar 27, 2025
pulisher
Mar 27, 2025

Metsera sees cash runway into 2027 - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Metsera reports Q4 EPS ($3.52) vs. (94c) last year - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Decoding Metsera Inc (MTSR): A Strategic SWOT Insight - GuruFocus

Mar 27, 2025
pulisher
Mar 26, 2025

Are Metsera Inc’shares a good deal? - US Post News

Mar 26, 2025
pulisher
Mar 26, 2025

Metsera's Q4 Net Loss Widens, Operating Expenses Rise; Shares Higher - marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

Metsera Reports Fourth Quarter And Full Year 2024 Financial Results And Continued Portfolio Progress - Marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

Form 10-K Metsera, Inc. For: Dec 31 - StreetInsider

Mar 26, 2025
pulisher
Mar 26, 2025

Earnings Flash (MTSR) Metsera Posts Q4 Total Operating Expenses $64.5M - Marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

Earnings Flash (MTSR) Metsera Posts Q4 Net Loss of $3.52 a Share - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress - The Manila Times

Mar 26, 2025
pulisher
Mar 24, 2025

Metsera Inc (NASDAQ: MTSR) Stock Is Down -21.4% From Its Low: The Uptrend Is Still On - Stocks Register

Mar 24, 2025
pulisher
Mar 21, 2025

Amneal Digs Deeper Into GLP-1 Aspirations Following Metsera’s IPO - insights.citeline.com

Mar 21, 2025
pulisher
Mar 18, 2025

IHS Holding Posts Upbeat Earnings, Joins Tencent Music Entertainment, Elbit Systems And Other Big Stocks Moving Higher On TuesdayDiginex (NASDAQ:DGNX), China Liberal Education (NASDAQ:CLEU) - Benzinga

Mar 18, 2025
pulisher
Mar 15, 2025

Metsera, Inc. (MTSR): Among Top Insider Purchases Last Month - Insider Monkey

Mar 15, 2025
pulisher
Mar 12, 2025

Top 10 Insider Purchases Last Month - Insider Monkey

Mar 12, 2025
pulisher
Mar 10, 2025

Metsera, Inc. awards full bonuses to executive officers By Investing.com - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Metsera, Inc. awards full bonuses to executive officers - Investing.com India

Mar 10, 2025
pulisher
Mar 10, 2025

Metsera, Inc. Approves 2024 Executive Cash Bonuses - TipRanks

Mar 10, 2025
pulisher
Mar 06, 2025

Is Metsera, Inc. (MTSR) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey

Mar 06, 2025
pulisher
Mar 05, 2025

Why MicroStrategy Incorporated (MSTR) Soared on Tuesday - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

Metsera, Inc.’s Quiet Period To Expire on March 12th (NASDAQ:MTSR) - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey

Mar 04, 2025
pulisher
Mar 04, 2025

Why Did MTSR Stock Surge 15% On The Worst Trading Day Of 2025? Here's What Has Happened Since Its Listing - NewsBreak

Mar 04, 2025
pulisher
Mar 04, 2025

Why Did Metsera Stock Surge 15% On The Worst Trading Day Of 2025? Here's What Has Happened Since Its Listing - Benzinga

Mar 04, 2025
pulisher
Mar 03, 2025

Metsera, Inc. (MTSR): Among Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey

Mar 03, 2025
pulisher
Mar 03, 2025

10 Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey

Mar 03, 2025
pulisher
Mar 03, 2025

AbbVie Buys Into Obesity With Gubra Deal, While Novo Partners With Gensaic - insights.citeline.com

Mar 03, 2025
pulisher
Feb 28, 2025

10 Best Weight Loss Drug Stocks to Buy According to Analysts - Insider Monkey

Feb 28, 2025
pulisher
Feb 27, 2025

CenExel Supports Metsera, Inc. in Successful Phase II Trial of MET-097 for Obesity and Metabolic Diseases - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 26, 2025

Metsera to Present at TD Cowen's 45th Annual Health Care Conference - The Manila Times

Feb 26, 2025
pulisher
Feb 26, 2025

Metsera to Present at TD Cowen’s 45th Annual Health Care Conference - The Bakersfield Californian

Feb 26, 2025
pulisher
Feb 26, 2025

Metsera: Capturing Of Obesity Market With Long-Acting GLP-1 Differentiation - Seeking Alpha

Feb 26, 2025
pulisher
Feb 26, 2025

Metsera (NASDAQ:MTSR) Now Covered by Bank of America - Defense World

Feb 26, 2025
pulisher
Feb 26, 2025

Metsera (NASDAQ:MTSR) Now Covered by Analysts at Evercore ISI - Defense World

Feb 26, 2025
pulisher
Feb 25, 2025

Metsera started by Guggenheim at buy on obesity drug opportunity - MSN

Feb 25, 2025
pulisher
Feb 25, 2025

Wall Street bullish on Metsera following January IPO on obesity drug pipeline - Investing.com Canada

Feb 25, 2025
pulisher
Feb 25, 2025

Metsera started at buy at Guggenheim on obesity treatment potential - MSN

Feb 25, 2025
pulisher
Feb 25, 2025

Why this newly public biotech could become a force in obesity treatments - MarketWatch

Feb 25, 2025
pulisher
Feb 25, 2025

90% upside? This weight-loss drug play is worth a look - Invezz

Feb 25, 2025
pulisher
Feb 25, 2025

This weight-loss drug stock could deliver a 90% return in 2025 - TradingView

Feb 25, 2025
pulisher
Feb 25, 2025

Cantor Fitzgerald initiates Metsera with overweight rating - Investing.com India

Feb 25, 2025
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
大文字化:     |  ボリューム (24 時間):